U.S. flag An official website of the United States government
  1. Home
  2. About FDA
  3. Performance Data
  4. FDA-TRACK: Agency-wide Program Performance
  5. FDA-TRACK: Animal Drug User Fee Act Animal Drug Applications and Supplements
  1. FDA-TRACK: Agency-wide Program Performance

FDA-TRACK: Animal Drug User Fee Act Animal Drug Applications and Supplements

On September 30, 2023, the fourth reauthorization of the Animal Drug User Fee Act (ADUFA), referred to as ADUFA V, was signed into law. ADUFA V amends the Federal Food, Drug, and Cosmetic Act (FD&C Act) by reauthorizing ADUFA for an additional five years (FY 2024 through FY 2028). ADUFA provides FDA with revenue to enhance the performance and predictability in review times for the animal drug industry and provides FDA with resources to improve its review of applications for new animal drugs, with the result that safe and effective new products will be more readily available.

Download Animal Drug Applications and Supplements Dataset


Footnotes:

  1. * Performance is currently preliminary due to pending submissions.
  2. ^ FY 2024 YTD includes preliminary performance as of 3/31/2024.
  3. ADUFA III performance goals and commitments applicable FY 2014 - FY 2018.
  4. ADUFA IV performance goals and commitments applicable FY 2019 - FY 2023.
  5. ADUFA V performance goals and commitments applicable FY 2024 - FY 2028.

Note: The data provided on this website are produced on an ongoing basis for performance management purposes and are subject to change due to updates of preliminary estimates, corrections, or other reasons.

 

Sign up to receive FDA-TRACK updates

Get regular FDA email updates delivered on this topic to your inbox.

Back to Top